The mean body mass index (BMI) and the prevalence of obesity both dropped in 2023 for the first time in more than a decade.

The US data suggest that the South has seen the greatest shifts, and the highest rate of GLP-1 prescribing per capita.

For most of Nancy Manther’s life, there’s been a nearly-constant chatter in her brain focused on food and diet. It was an ...

A new weight loss treatment known as tripeptide (Mounjaro) is expected to be rolled out via the NHS in March 2025 ...

The NHS has released an online tool to help patients check if they are eligible for certain weight loss medications - use the ...

A new weight loss treatment known as tripeptide (Mounjaro) is expected to be rolled out via the NHS in March 2025 ...

Human reproduction is influenced by a complex interplay of biology, genetics, and socioeconomic factors. Over the past few ...

Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...

On its own, obesity can cause acute ailments, including breathlessness and back pain. Worse, it often leads to other chronic ...

More recent birth cohorts have lower levels of total cholesterol and fasting triglyceride levels, and higher levels of fasting glucose.

The most common symptoms in individuals with likely long COVID included fatigue, post-exertional malaise, post-exertional ...

For the first time in a decade, the United States is seeing a slight decline in obesity rates. A new study published in JAMA ...